View:
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
December 4, 1996
----------------
(Date of earliest event reported)
LABORATORY CORPORATION OF AMERICA HOLDINGS
------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 1-11353 13-3757370
-------- ------- ----------
(State or other (Commission (IRS Employer
jurisdiction or File Number) Identification
organization) Number)
358 South Main Street, Burlington, North Carolina 27215
--------------------------------------------------------
(Address of principal executive offices)
910-229-1127
------------
(Registrant's telephone number, including area code)
Item 5. Other Events
On December 4, 1996, the Company issued a press release
announcing the resignation of David C. Weavil, Executive Vice
President and Chief Operating Officer and that Ronald B.
Sturgill, Executive Vice President, is assuming responsibilities
as Chief Operating Officer until a successor is named. The press
release is attached as an exhibit hereto and the text thereof is
incorporated in its entirety herein by reference.
Item 7. Financial Statements, Pro Forma Financial
Information and Exhibits
(c) Exhibits
20 Press release of the Registrant dated December 4, 1996.
SIGNATURES
Pursuant to the requirements of the Securities and Exchange
Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned hereunto duly authorized.
LABORATORY CORPORATION OF AMERICA HOLDINGS
------------------------------------------
(Registrant)
By: /s/ BRADFORD T. SMITH
---------------------------------------------
Bradford T. Smith
Executive Vice President, General
Counsel and Secretary
Date: December 4, 1996
Exhibit 20
FOR IMMEDIATE RELEASE
Contact: Pamela Sherry
Telephone: (910) 584-5171
Ext. 6768
LABORATORY CORPORATION OF AMERICA ANNOUNCES RESIGNATION OF DAVID
C. WEAVIL, EVP AND COO
Burlington, NC, December 4, 1996 -- Laboratory Corporation of
America Holdings (LabCorp) (NYSE: LH) today announced the
resignation of David C. Weavil, Executive Vice President and
Chief Operating Officer, effective immediately. Mr. Weavil's
resignation came as a result of LabCorp's recently announced
government settlement, and resolves all issues related to 1993-
initiated federal investigations of prior billing practices for
LabCorp's predecessor companies. These investigations, which
were part of a broad-based inquiry into industry-wide billing
practices, have resulted in settlements with a number of other
clinical laboratories to date and are expected to result in
additional settlements in the near future.
Ronald B. Sturgill, Executive Vice President, is assuming
responsibilities as Chief Operating Officer until a successor is
named. Mr. Sturgill, whose current responsibilities include
Human Resources and the South Atlantic Operating Division, is a
25-year veteran of the Company and the clinical laboratory
industry.
Laboratory Corporation of America Holdings (LabCorp) is a
national clinical laboratory organization with estimated
annualized revenues of $1.6 billion. The Company operates
primary testing facilities nationally, offering more than 1,700
different clinical assays, from routine blood analysis to more
sophisticated technologies. LabCorp performs diagnostic tests
for physicians, managed care organizations, hospitals, clinics,
long-term care facilities, industrial companies and other
clinical laboratories.
###